Literature DB >> 12390432

Allogeneic bone marrow transplantation for infantile globoid-cell leukodystrophy (Krabbe's disease).

Maurizio Caniglia1, Ippolita Rana, Rita Maria Pinto, Giuseppe Fariello, Roberta Caruso, Adriano Angioni, Carlo Dionisi Vici, Gaetano Sabetta, Giulio De Rossi.   

Abstract

A 4-month-old-girl affected by early expression of Krabbe's disease was treated with allogeneic bone marrow transplantation (BMT). The stem cell donor was her heterozygous HLA-identical mother. The central nervous system (CNS) involvement at diagnosis was evident, but minimal. After BMT the child presented a severe hypotonia and an acute tetraventricular hydrocephalus; she died 180 days after the BMT with progressive severe neurologic deterioration. Leukocyte galactocerebrosidase (GALC) activity was present at donor levels 20 days after BMT. Full donor chimerism was evident 18 days after BMT. This report confirms that in early onset "Krabbe's syndrome" if the diagnosis is delayed after the birth, the progression of the neurologic deterioration is not reversed by BMT. It is to be demonstrated if a very early hemopoietic stem cell transplantation during the first weeks of life, could be appropriate and efficacious.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12390432     DOI: 10.1034/j.1399-3046.2002.02026.x

Source DB:  PubMed          Journal:  Pediatr Transplant        ISSN: 1397-3142


  9 in total

Review 1.  Cellular transplant therapies for globoid cell leukodystrophy: Preclinical and clinical observations.

Authors:  Keri R Maher; Andrew M Yeager
Journal:  J Neurosci Res       Date:  2016-11       Impact factor: 4.164

Review 2.  Treatment for Krabbe's disease: Finding the combination.

Authors:  Christina R Mikulka; Mark S Sands
Journal:  J Neurosci Res       Date:  2016-11       Impact factor: 4.164

3.  Delivering drugs to the central nervous system: an overview.

Authors:  Patricia I Dickson
Journal:  Drug Deliv Transl Res       Date:  2012-06       Impact factor: 4.617

4.  Newborn screening for lysosomal storage diseases: an ethical and policy analysis.

Authors:  Lainie Friedman Ross
Journal:  J Inherit Metab Dis       Date:  2011-12-22       Impact factor: 4.982

Review 5.  Potential use of stem cells as a therapy for cystinosis.

Authors:  Celine J Rocca; Stephanie Cherqui
Journal:  Pediatr Nephrol       Date:  2018-05-22       Impact factor: 3.714

6.  Effect of intrastriatal mesenchymal stromal cell injection on progression of a murine model of Krabbe disease.

Authors:  Shawna E Wicks; Heaven Londot; Bo Zhang; Jennifer Dowden; Jessica Klopf-Eiermann; Jeanne M Fisher-Perkins; Cynthia B Trygg; Brittni A Scruggs; Xiujuan Zhang; Jeffrey M Gimble; Bruce A Bunnell; Paul J Pistell
Journal:  Behav Brain Res       Date:  2011-08-05       Impact factor: 3.332

7.  Spontaneous Third Ventriculostomy in Krabbe Disease.

Authors:  Giulio Zuccoli; Aram Kim; Michele Poe; Maria L Escolar
Journal:  Pediatr Neurol       Date:  2019-12-02       Impact factor: 3.372

8.  GC-EI-MS analysis of fatty acid composition in brain and serum of twitcher mouse.

Authors:  Assunta Zanfini; Elena Dreassi; Anna Berardi; Paola Piomboni; Elvira Costantino-Ceccarini; Alice Luddi
Journal:  Lipids       Date:  2014-09-11       Impact factor: 1.880

Review 9.  A neglected neurodegenerative disease: Adult-onset globoid cell leukodystrophy.

Authors:  Guode Wu; Zhenhua Li; Jing Li; Xin Li; Manxia Wang; Jing Zhang; Guangyao Liu; Pengfei Zhang
Journal:  Front Neurosci       Date:  2022-09-07       Impact factor: 5.152

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.